Melanoma simulating atypical fibroxanthoma.

dc.contributor.authorSangüeza, Martin
dc.contributor.authorZelger, Bernhard
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:07:44Z
dc.date.available2026-03-24T15:07:44Z
dc.date.issued2007
dc.descriptionVol. 29, No. 6, pp. 551-4
dc.description.abstractMelanoma may present with a wide variety of clinicopathological presentations, among those very rarely lesions imitating atypical fibroxanthoma (AFX). While AFX usually is cured by complete excision, melanoma simulating AFX has a much more serious prognosis, and thus is important to be recognized correctly. The present series describes 4 cases of such melanomas in 3 patients whose exact diagnosis was (markedly) delayed due to unusual clinicopathological presentations including negative immunohistochemistry for melanocytic markers (S100 protein, MelanA/MART1, HMB45).eng
dc.description.sponsorshipDepartment of Pathology, Hospital Obrero Nro 1, Caja Nacional De Salud, La Paz, Bolivia.
dc.identifier.doi10.1097/DAD.0b013e31815936ff
dc.identifier.issn1533-0311
dc.identifier.otherPMID:18032950
dc.identifier.urihttps://doi.org/10.1097/DAD.0b013e31815936ff
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101366
dc.language.isoeng
dc.relation.ispartofThe American Journal of dermatopathology
dc.sourcePubMed
dc.titleMelanoma simulating atypical fibroxanthoma.
dc.typeArtículo Científico Publicado

Files